Zhao-Dong Zhong
Overview
Explore the profile of Zhao-Dong Zhong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang R, Lu X, Tang L, Wang H, Yan H, You Y, et al.
Bone Marrow Transplant
. 2022 Apr;
57(7):1063-1071.
PMID: 35459877
The optimal conditioning regimen for high-risk myelodysplastic syndrome (MDS) patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains elusive. This study aimed to explore the anti-leukemic efficacy and toxicity of...
2.
Ma S, Yan H, Shi W, You Y, Zhong Z, Hu Y
Medicine (Baltimore)
. 2020 Sep;
99(33):e21752.
PMID: 32872067
Rationale: As the major complications post allogeneic hematopoietic stem cell transplantation (allo-HSCT), gastrointestinal disorders were most commonly ascribed to acute graft-versus-host disease (aGVHD) and opportunistic infections. Though Giardia lamblia (G...
3.
Dang S, Liu Q, Xie R, Shen N, Zhou S, Shi W, et al.
World J Clin Cases
. 2020 Apr;
8(6):1065-1073.
PMID: 32258077
Background: Graft--host disease (GVHD) is a major cause of mortality after allogeneic hematopoietic stem cell transplantation. Some patients have steroid-refractory (SR) GVHD. Aim: To evaluate the effect and safety of...
4.
Shen N, You Y, Zhong Z, Meng L, Zhou J, Zou P, et al.
Curr Med Sci
. 2019 Apr;
39(2):211-216.
PMID: 31016512
Discontinuation of tyrosine kinase inhibitor (TKI) therapy after achieving a persistent deep molecular response (DMR) is an urgently needed treatment goal for chronic myeloid leukemia (CML) patients and has been...
5.
Chen L, Yuan G, Zhong Z, Zou P, Li D, Bao Y, et al.
Curr Med Sci
. 2018 Dec;
38(6):1005-1011.
PMID: 30536062
Dasatinib is a second-generation tyrosine kinase inhibitor (TKI) and it could be used as a second-line treatment for patients with chronic myeloid leukemia (CML). Yinishu, a generic dasatinib made in...
6.
Cui J, Xiao Y, You Y, Shi W, Li Q, Luo Y, et al.
J Huazhong Univ Sci Technolog Med Sci
. 2017 Oct;
37(5):693-698.
PMID: 29058281
Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a main question on treatment failure. Current strategies for management that usually include salvage chemotherapy, donor lymphocytic infusion and second transplantation....
7.
Nie D, Wu Q, Zhu X, Zhang R, Zheng P, Fang J, et al.
J Huazhong Univ Sci Technolog Med Sci
. 2015 Oct;
35(5):694-699.
PMID: 26489624
Acute graft-versus-host disease (aGVHD) is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the mechanisms of aGVHD are not well understood. We aim to investigate the roles...
8.
Wu Q, Liu X, Nie D, Zhu X, Fang J, You Y, et al.
J Huazhong Univ Sci Technolog Med Sci
. 2015 Jul;
35(4):477-484.
PMID: 26223913
Although mesenchymal stem cells (MSCs) are increasingly used to treat graft-versus-host disease (GVHD), their immune regulatory mechanism in the process is elusive. The present study aimed to investigate the curative...
9.
[Modified method for whole bone marrow adherent culture of human bone marrow mesenchymal stem cells]
Wang X, Zhong Z, Chen Z, Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2014 Apr;
22(2):496-502.
PMID: 24763030
This study was aimed to investigate a more convenient and efficient method to cultivate the human bone marrow mesenchymal stem cells by means of natural erythrocyte sedimentation principle, based on...
10.
Zhu X, Li Y, You Y, Li Q, Zeng C, Zhong Z, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2014 Mar;
22(1):154-9.
PMID: 24598669
This study was aimed to investigate the effect of exogenous VEGF on hematopoietic stem cell mobilization and immune system. The C57BL/6J mice were randomly divided into the normal control group,...